State Issues
MassBio is the voice of the industry on Beacon Hill. We educate policy makers about our specific needs and our significance to the economy. We also work with them to develop laws, regulations and tax policies that will foster an expansion of the life sciences supercluster in the Commonwealth.
Members: Download the list of MassBio's 2011-2012 Legislative Priorities & Legislative tracker here.

Economic Development
A favorable business and policy climate will allow the life sciences to grow in Massachusetts despite increasing competition from other states and countries seeking a bigger share of the sector.
Read more
Workforce Development
Research shows Massachusetts must improve, expand and tailor its educational programs and resources designed to prepare students and workers for jobs in life sciences sectors, to ensure that the industry will have the talent it needs to grow in the Commonwealth over the next decade.
Read more
Drug Price Controls
Targeted government programs and cooperative industry efforts will help maintain reasonable drug costs for all without choking innovation.
Read more
Drug Importation
Effective government programs to prevent the illegal importation of drugs from other countries will ensure that Americans have access to the safest, most reliable products on the market.
Read more
Drug Market Regulation
Public policies must prevent unwanted conflicts of interest in drug marketing without keeping crucial information from patients, doctors and researchers.
Read more
Recent News
- February 2, 2012 NUCLEA BIOTECHNOLOGIES ANNOUNCES $3.4 MILLION IN CAPITAL COMMITMENTS
- January 30, 2012 Annual Policy Breakfast Makes Headlines on Healthcare Reform
- January 24, 2012 MassBio Introduces the Leading Edge Award
- January 23, 2012 MassBio Policy Update - SBIR Reauthorization
- January 18, 2012 451 Marketing & Freeman to Create Massachusetts Pavilion at 2012 BIO International Convention